Scholarlink

Aim <p>&#xa0;Undifferentiated embryonal sarcoma of the liver (UESL) presents significant diagnostic and therapeutic challenges due to its rarity and unpredictable clinical course. This study emphasizes the importance of individualized, case-based assessment by highlighting the distinctive preoperative, intraoperative, and postoperative challenges encountered in pediatric UESL patients.</p> Material and methods <p>&#xa0;We performed a retrospective review of nine pediatric patients treated for UESL at our institution from 2012 to 2022. We systematically evaluated clinical presentations, radiological assessments, surgical techniques, perioperative findings, treatment protocols, and follow-up outcomes.</p> Results <p>&#xa0;Each patient presented unique diagnostic and therapeutic challenges at various management stages. Preoperatively, overlapping radiologic and immunohistochemical features led to diagnostic uncertainty; notably, weak β-catenin positivity and low AFP levels initially resulted in misdiagnosis and incorrect treatment protocol application in one case. Significant intraoperative events included unexpected pulmonary embolism, while another patient developed posterior reversible encephalopathy syndrome (PRES) immediately preoperatively, delaying surgical intervention. Excluding one patient who experienced an unexplained sudden death on postoperative day 5, no other major surgical complications (such as hemorrhage, infection, bile leakage, biliary complications, or sepsis) were recorded. At a median follow-up of 7.2&#xa0;years (range: 13&#xa0;months to 12&#xa0;years), five patients remained disease-free, one patient continued with intermittent chemotherapy, two patients succumbed to progressive metastatic recurrence, and one patient died postoperatively on day 5 due to an unexplained event.</p> Conclusion <p>&#xa0;UESL requires individualized, case-based evaluation and multidisciplinary collaboration. Each patient may present unique diagnostic, surgical, and postoperative management challenges. Awareness of potential complications and the unpredictable nature of UESL highlights the importance of centralized, multidisciplinary care to optimize clinical outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A journey full of surprises: surgical insights from pediatric undifferentiated embryonal liver sarcomas

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月25日

查看全文
  • Senol Emre,
  • Ayse Karagoz,
  • Ali Ekber Hakalmaz,
  • Suheyla Ocak,
  • Ayse Kalyoncu Ucar,
  • Nuray Kepil,
  • Pinar Kendigelen,
  • Cigdem Tutuncu,
  • Sebuh Kurugoglu,
  • Osman Faruk Senyuz

摘要

Aim

 Undifferentiated embryonal sarcoma of the liver (UESL) presents significant diagnostic and therapeutic challenges due to its rarity and unpredictable clinical course. This study emphasizes the importance of individualized, case-based assessment by highlighting the distinctive preoperative, intraoperative, and postoperative challenges encountered in pediatric UESL patients.

Material and methods

 We performed a retrospective review of nine pediatric patients treated for UESL at our institution from 2012 to 2022. We systematically evaluated clinical presentations, radiological assessments, surgical techniques, perioperative findings, treatment protocols, and follow-up outcomes.

Results

 Each patient presented unique diagnostic and therapeutic challenges at various management stages. Preoperatively, overlapping radiologic and immunohistochemical features led to diagnostic uncertainty; notably, weak β-catenin positivity and low AFP levels initially resulted in misdiagnosis and incorrect treatment protocol application in one case. Significant intraoperative events included unexpected pulmonary embolism, while another patient developed posterior reversible encephalopathy syndrome (PRES) immediately preoperatively, delaying surgical intervention. Excluding one patient who experienced an unexplained sudden death on postoperative day 5, no other major surgical complications (such as hemorrhage, infection, bile leakage, biliary complications, or sepsis) were recorded. At a median follow-up of 7.2 years (range: 13 months to 12 years), five patients remained disease-free, one patient continued with intermittent chemotherapy, two patients succumbed to progressive metastatic recurrence, and one patient died postoperatively on day 5 due to an unexplained event.

Conclusion

 UESL requires individualized, case-based evaluation and multidisciplinary collaboration. Each patient may present unique diagnostic, surgical, and postoperative management challenges. Awareness of potential complications and the unpredictable nature of UESL highlights the importance of centralized, multidisciplinary care to optimize clinical outcomes.